Fungal Keratitis Treatment Market Size, Share & Trends Report

Fungal Keratitis Treatment Market Size, Share & Trends Analysis Report By Type (Antiviral Drugs, Antihistamines, Vaccines, Other), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-193-6
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Antifungal Drugs Market: Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Drug Class
                       1.2.2. Indication
                       1.2.3. Dosage Form
                       1.2.4. Distribution Channel
                       1.2.5. Regional scope
                       1.2.6. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in North America
                           1.4.5.2. Data for primary interviews in Europe
                           1.4.5.3. Data for primary interviews in Asia Pacific
                           1.4.5.4. Data for primary interviews in Latin America
                           1.4.5.5. Data for Primary interviews in MEA
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Antifungal Drugs Market: Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Drug Class outlook
                       2.2.2. Indication outlook
                       2.2.3. Dosage Form outlook
                       2.2.4. Distribution Channel outlook
                       2.2.5. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Antifungal Drugs Market: Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing Incidence Of Fungal Infections
                           3.2.1.2. Increase In Awareness
                           3.2.1.3. Rising R & D Pertaining To The Development Of Novel Drugs
                       3.2.2. Market restraint analysis
                           3.2.2.1. High Cost Associated With Mrd Testing
                           3.2.2.2. Complex Regulatory Framework Associated With Mrd Testing
                   3.3. Antifungal Drugs Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. Antifungal Drugs Market: Drug Class Estimates & Trend Analysis
                   4.1. Drug Class Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. Global Antifungal Drugs Market by Drug Class Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.4.1. Azoles
                           4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.2. Echinocandins
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.3. Polyenes
                           4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.4. Allylamines
                           4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.5. Others
                           4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Antifungal Drugs Market: Indication Estimates & Trend Analysis
                   5.1. Indication Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. Global Antifungal Drugs Market by Indication Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.4.1. Dermatophytosis
                           5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. Aspergillosis
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.3. Candidiasis
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.4. Others
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Antifungal Drugs Market: Dosage Form Estimates & Trend Analysis
                   6.1. Dosage Form Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. Global Antifungal Drugs Market by Dosage Form Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.4.1. Oral Drugs
                           6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.2. Ointments
                           6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.3. Powders
                           6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.4. Others
                           6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Antifungal Drugs Market: Distribution Channel Estimates & Trend Analysis
                   7.1. Distribution Channel Market Share, 2023 & 2030
                   7.2. Segment Dashboard
                   7.3. Global Antifungal Drugs Market by Distribution Channel Outlook
                   7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       7.4.1. Hospital Pharmacies
                           7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       7.4.2. Retails Pharmacies
                           7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       7.4.3. Others
                           7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Antifungal Drugs Market: Regional Estimates & Trend Analysis
                   8.1. Regional Market Share Analysis, 2023 & 2030
                   8.2. Regional Market Dashboard
                   8.3. Global Regional Market Snapshot
                   8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                   8.5. North America
                       8.5.1. U.S.
                           8.5.1.1. Key country dynamics
                           8.5.1.2. Regulatory framework/ reimbursement structure
                           8.5.1.3. Competitive scenario
                           8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.2. Canada
                           8.5.2.1. Key country dynamics
                           8.5.2.2. Regulatory framework/ reimbursement structure
                           8.5.2.3. Competitive scenario
                           8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                   8.6. Europe
                       8.6.1. UK
                           8.6.1.1. Key country dynamics
                           8.6.1.2. Regulatory framework/ reimbursement structure
                           8.6.1.3. Competitive scenario
                           8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.2. Germany
                           8.6.2.1. Key country dynamics
                           8.6.2.2. Regulatory framework/ reimbursement structure
                           8.6.2.3. Competitive scenario
                           8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.3. France
                           8.6.3.1. Key country dynamics
                           8.6.3.2. Regulatory framework/ reimbursement structure
                           8.6.3.3. Competitive scenario
                           8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.4. Italy
                           8.6.4.1. Key country dynamics
                           8.6.4.2. Regulatory framework/ reimbursement structure
                           8.6.4.3. Competitive scenario
                           8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.5. Spain
                           8.6.5.1. Key country dynamics
                           8.6.5.2. Regulatory framework/ reimbursement structure
                           8.6.5.3. Competitive scenario
                           8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.6. Norway
                           8.6.6.1. Key country dynamics
                           8.6.6.2. Regulatory framework/ reimbursement structure
                           8.6.6.3. Competitive scenario
                           8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.7. Sweden
                           8.6.7.1. Key country dynamics
                           8.6.7.2. Regulatory framework/ reimbursement structure
                           8.6.7.3. Competitive scenario
                           8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.8. Denmark
                           8.6.8.1. Key country dynamics
                           8.6.8.2. Regulatory framework/ reimbursement structure
                           8.6.8.3. Competitive scenario
                           8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                   8.7. Asia Pacific
                       8.7.1. Japan
                           8.7.1.1. Key country dynamics
                           8.7.1.2. Regulatory framework/ reimbursement structure
                           8.7.1.3. Competitive scenario
                           8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.2. China
                           8.7.2.1. Key country dynamics
                           8.7.2.2. Regulatory framework/ reimbursement structure
                           8.7.2.3. Competitive scenario
                           8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.3. India
                           8.7.3.1. Key country dynamics
                           8.7.3.2. Regulatory framework/ reimbursement structure
                           8.7.3.3. Competitive scenario
                           8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.4. Australia
                           8.7.4.1. Key country dynamics
                           8.7.4.2. Regulatory framework/ reimbursement structure
                           8.7.4.3. Competitive scenario
                           8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.5. South Korea
                           8.7.5.1. Key country dynamics
                           8.7.5.2. Regulatory framework/ reimbursement structure
                           8.7.5.3. Competitive scenario
                           8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.6. Thailand
                           8.7.6.1. Key country dynamics
                           8.7.6.2. Regulatory framework/ reimbursement structure
                           8.7.6.3. Competitive scenario
                           8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                   8.8. Latin America
                       8.8.1. Brazil
                           8.8.1.1. Key country dynamics
                           8.8.1.2. Regulatory framework/ reimbursement structure
                           8.8.1.3. Competitive scenario
                           8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                       8.8.2. Mexico
                           8.8.2.1. Key country dynamics
                           8.8.2.2. Regulatory framework/ reimbursement structure
                           8.8.2.3. Competitive scenario
                           8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                       8.8.3. Argentina
                           8.8.3.1. Key country dynamics
                           8.8.3.2. Regulatory framework/ reimbursement structure
                           8.8.3.3. Competitive scenario
                           8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                   8.9. MEA
                       8.9.1. South Africa
                           8.9.1.1. Key country dynamics
                           8.9.1.2. Regulatory framework/ reimbursement structure
                           8.9.1.3. Competitive scenario
                           8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                       8.9.2. Saudi Arabia
                           8.9.2.1. Key country dynamics
                           8.9.2.2. Regulatory framework/ reimbursement structure
                           8.9.2.3. Competitive scenario
                           8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                       8.9.3. UAE
                           8.9.3.1. Key country dynamics
                           8.9.3.2. Regulatory framework/ reimbursement structure
                           8.9.3.3. Competitive scenario
                           8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                       8.9.4. Kuwait
                           8.9.4.1. Key country dynamics
                           8.9.4.2. Regulatory framework/ reimbursement structure
                           8.9.4.3. Competitive scenario
                           8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Recent Developments & Impact Analysis, By Key Market Participants
                   9.2. Company/Competition Categorization
                   9.3. Vendor Landscape
                       9.3.1. List of key distributors and channel partners
                       9.3.2. Key customers
                       9.3.3. Key company market share analysis, 2023
                       9.3.4. NOVARTIS AG
                           9.3.4.1. Company overview
                           9.3.4.2. Financial performance
                           9.3.4.3. Product benchmarking
                           9.3.4.4. Strategic initiatives
                       9.3.5. PFIZER, INC.
                           9.3.5.1. Company overview
                           9.3.5.2. Financial performance
                           9.3.5.3. Product benchmarking
                           9.3.5.4. Strategic initiatives
                       9.3.6. BAYER AG
                           9.3.6.1. Company overview
                           9.3.6.2. Financial performance
                           9.3.6.3. Product benchmarking
                           9.3.6.4. Strategic initiatives
                       9.3.7. SANOFI
                           9.3.7.1. Company overview
                           9.3.7.2. Financial performance
                           9.3.7.3. Product benchmarking
                           9.3.7.4. Strategic initiatives
                       9.3.8. MERCK & CO., INC.
                           9.3.8.1. Company overview
                           9.3.8.2. Financial performance
                           9.3.8.3. Product benchmarking
                           9.3.8.4. Strategic initiatives
                       9.3.9. F. GSK PLC
                           9.3.9.1. Company overview
                           9.3.9.2. Financial performance
                           9.3.9.3. Product benchmarking
                           9.3.9.4. Strategic initiatives
                       9.3.10. ABBOTT
                           9.3.10.1. Company overview
                           9.3.10.2. Financial performance
                           9.3.10.3. Product benchmarking
                           9.3.10.4. Strategic initiatives
                       9.3.11. GLENMARK
                           9.3.11.1. Company overview
                           9.3.11.2. Financial performance
                           9.3.11.3. Product benchmarking
                           9.3.11.4. Strategic initiatives
                       9.3.12. ASTELLAS PHARMA, INC.
                           9.3.12.1. Company overview
                           9.3.12.2. Financial performance
                           9.3.12.3. Product benchmarking
                           9.3.12.4. Strategic initiatives
                       9.3.13. SCYNEXIS INC.
                           9.3.13.1. Company overview
                           9.3.13.2. Financial performance
                           9.3.13.3. Product benchmarking
                           9.3.13.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America antifungal drugs market, by region, 2018 - 2030 (USD Million)
Table 3 North America antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 4 North America antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 5 North America antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 6 North America antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 U.S. antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 8 U.S. antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 9 U.S. antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 10 U.S. antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 12 Canada antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 13 Canada antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 14 Canada antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe antifungal drugs market, by region, 2018 - 2030 (USD Million)
Table 16 Europe antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 17 Europe antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 18 Europe antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 19 Europe antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Germany antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 21 Germany antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 22 Germany antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 23 Germany antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 UK antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 25 UK antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 26 UK antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 27 UK antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 France antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 29 France antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 30 France antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 31 France antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Italy antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 33 Italy antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 34 Italy antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 35 Italy antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Spain antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 37 Spain antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 38 Spain antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 39 Spain antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Denmark antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 41 Denmark antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 42 Denmark antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 43 Denmark antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 Sweden antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 45 Sweden antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 46 Sweden antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 47 Sweden antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Norway antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 49 Norway antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 50 Norway antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 51 Norway antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Asia Pacific antifungal drugs market, by region, 2018 - 2030 (USD Million)
Table 53 Asia Pacific antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 54 Asia Pacific antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 55 Asia Pacific antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 56 Asia Pacific antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 China antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 58 China antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 59 China antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 60 China antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Japan antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 62 Japan antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 63 Japan antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 64 Japan antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 India antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 66 India antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 67 India antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 68 India antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 69 South Korea antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 70 South Korea antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 71 South Korea antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 72 South Korea antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 73 Australia antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 74 Australia antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 75 Australia antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 76 Australia antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 77 Thailand antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 78 Thailand antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 79 Thailand antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 80 Thailand antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 Latin America antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 82 Latin America antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 83 Latin America antifungal drugs market, by application, 2018 - 2030 (USD Million)
Table 84 Latin America antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 85 Latin America antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 86 Brazil antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 87 Brazil antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 88 Brazil antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 89 Brazil antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 90 Mexico antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 91 Mexico antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 92 Mexico antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 93 Mexico antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 94 Argentina antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 95 Argentina antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 96 Argentina antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 97 Argentina antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 98 MEA antifungal drugs market, by region, 2018 - 2030 (USD Million)
Table 99 MEA antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 100 MEA antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 101 MEA antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 102 MEA antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 103 South Africa antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 104 South Africa antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 105 South Africa antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 106 South Africa antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 UAE antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 112 UAE antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 113 UAE antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 114 UAE antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 115 Kuwait antifungal drugs market, by drug class, 2018 - 2030 (USD Million)
Table 116 Kuwait antifungal drugs market, by Indication, 2018 - 2030 (USD Million)
Table 117 Kuwait antifungal drugs market, by dosage form, 2018 - 2030 (USD Million)
Table 118 Kuwait antifungal drugs market, by distribution channel, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Antifungal drugs market: market outlook
Fig. 14 Antifungal drugs competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Antifungal drugs market driver impact
Fig. 20 Antifungal drugs market restraint impact
Fig. 21 Antifungal drugs market strategic initiatives analysis
Fig. 22 Antifungal drugs market: Drug Class movement analysis
Fig. 23 Antifungal drugs market: Drug Class outlook and key takeaways
Fig. 24 Azoles market estimates and forecast, 2018 - 2030
Fig. 25 Echinocandins market estimates and forecast, 2018 - 2030
Fig. 26 Polyenes market estimates and forecast, 2018 - 2030
Fig. 27 Allylamines market estimates and forecast, 2018 - 2030
Fig. 28 Others market estimates and forecast, 2018 - 2030
Fig. 29 Antifungal drugs market: Indication movement Analysis
Fig. 30 Antifungal drugs market: Indication outlook and key takeaways
Fig. 31 Dermatophytosis market estimates and forecasts, 2018 - 2030
Fig. 32 Aspergillosis market estimates and forecasts,2018 - 2030
Fig. 33 Candidiasis market estimates and forecasts, 2018 - 2030
Fig. 34 Others market estimates and forecasts,2018 - 2030
Fig. 35 Antifungal drugs market: Dosage form movement Analysis
Fig. 36 Antifungal drugs market: Dosage form outlook and key takeaways
Fig. 37 Oral drugs market estimates and forecasts, 2018 - 2030
Fig. 38 Ointments market estimates and forecasts,2018 - 2030
Fig. 39 Powders market estimates and forecasts, 2018 - 2030
Fig. 40 Others market estimates and forecasts,2018 - 2030
Fig. 41 Antifungal drugs market: Distribution channel movement Analysis
Fig. 42 Antifungal drugs market: Distribution channel outlook and key takeaways
Fig. 43 Hospital pharmacies market estimates and forecasts, 2018 - 2030
Fig. 44 Retail pharmacies market estimates and forecasts,2018 - 2030
Fig. 45 Others market estimates and forecasts,2018 - 2030
Fig. 46 Global antifungal drugs market: Regional movement analysis
Fig. 47 Global antifungal drugs market: Regional outlook and key takeaways
Fig. 48 Global antifungal drugs market share and leading players
Fig. 49 North America market share and leading players
Fig. 50 Europe market share and leading players
Fig. 51 Asia Pacific market share and leading players
Fig. 52 Latin America market share and leading players
Fig. 53 Middle East & Africa market share and leading players
Fig. 54 North America: SWOT
Fig. 55 Europe SWOT
Fig. 56 Asia Pacific SWOT
Fig. 57 Latin America SWOT
Fig. 58 MEA SWOT
Fig. 59 North America, by country
Fig. 60 North America
Fig. 61 North America market estimates and forecasts, 2018 - 2030
Fig. 62 U.S.
Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
Fig. 64 Canada
Fig. 65 Canada market estimates and forecasts, 2018 - 2030
Fig. 66 Europe
Fig. 67 Europe market estimates and forecasts, 2018 - 2030
Fig. 68 UK
Fig. 69 UK market estimates and forecasts, 2018 - 2030
Fig. 70 Germany
Fig. 71 Germany market estimates and forecasts, 2018 - 2030
Fig. 72 France
Fig. 73 France market estimates and forecasts, 2018 - 2030
Fig. 74 Italy
Fig. 75 Italy market estimates and forecasts, 2018 - 2030
Fig. 76 Spain
Fig. 77 Spain market estimates and forecasts, 2018 - 2030
Fig. 78 Denmark
Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
Fig. 80 Sweden
Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
Fig. 82 Norway
Fig. 83 Norway market estimates and forecasts, 2018 - 2030
Fig. 84 Asia Pacific
Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 86 China
Fig. 87 China market estimates and forecasts, 2018 - 2030
Fig. 88 Japan
Fig. 89 Japan market estimates and forecasts, 2018 - 2030
Fig. 90 India
Fig. 91 India market estimates and forecasts, 2018 - 2030
Fig. 92 Thailand
Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
Fig. 94 South Korea
Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
Fig. 96 Australia
Fig. 97 Australia market estimates and forecasts, 2018 - 2030
Fig. 98 Latin America
Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
Fig. 100 Brazil
Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
Fig. 102 Mexico
Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
Fig. 104 Argentina
Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
Fig. 106 Middle East and Africa
Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 108 South Africa
Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 112 UAE
Fig. 113 UAE market estimates and forecasts, 2018 - 2030
Fig. 114 Kuwait
Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 116 Market share of key market players- Antifungal drugs market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon